BCRX
#1875
BioCryst Pharmaceuticals, Inc. - Common Stock
9.4 6 USD
-0.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.87%
Changement Mensuel
+4.07%
Evolution sur 6 mois
+32.87%
Changement Annuel
+8.11%
Clôture Précédente
9.7 4
Open
9.4 2
Low
9.3 9
High
9.4 9
Volume
637
Financials
- Market Capitalization 2.4 B
- Employee 435
- Founded 1986
- CEO Jon P. Stonehouse
- Website www.biocryst.com
- Headquarter Delaware, United States
- FIGI BBG000BLYWX6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.38
ratio cours/chiffre d'affaires
2.4
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1849 |  IMNM Immunome, Inc. - Common Stock | 22.69 USD | +0.44% | -6.16% | +25.85% | +164.76% | 2.57 B USD | ||
| 1855 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 17.81 USD | -0.56% | -3.31% | +21.40% | +159.62% | 2.53 B USD | ||
| 1878 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.74 USD | +3.31% | -0.50% | +40.22% | +111.78% | 2.46 B USD | ||
| 1881 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 56.77 USD | +1.18% | -18.16% | -8.63% | -14.06% | 2.44 B USD |